Company · CIK 0001070081 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
PTC THERAPEUTICS, INC. · PTCT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 SForm 4 → | Sep 18, 5:20 pm EDT | Michael SchmertzlerDirector | 20,000 | $67.49 | $1,349,728 | 1,296,594 | −1.52% | 10b5-1 |
| Sep 9, 2026 SForm 4 → | Sep 11, 5:20 pm EDT | Michael SchmertzlerDirector | 20,000 | $67.59 | $1,351,803 | 1,316,594 | −1.50% | 10b5-1 |
| Aug 26, 2026 SForm 4 → | Aug 28, 5:20 pm EDT | Michael SchmertzlerDirector | 25,000 | $72.26 | $1,806,509 | 1,336,594 | −1.84% | 10b5-1 |
| Aug 19, 2026 SForm 4 → | Aug 21, 5:20 pm EDT | Michael SchmertzlerDirector | 25,000 | $72.22 | $1,805,411 | 1,361,594 | −1.80% | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 19, 5:20 pm EDT | Mark Elliott BouldingEXEC. VP AND CLO | 2,813 | $72.57 | $204,127 | 105,272 | −2.60% | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 19, 5:20 pm EDT | Mark Elliott BouldingEXEC. VP AND CLO | 2,813 | $25.69 | $72,266 | 108,085 | — | 10b5-1 |
| Aug 4, 2026 SForm 4 → | Aug 6, 5:20 pm EDT | Matthew B. KleinCHIEF EXECUTIVE OFFICER, Director | 10,292 | $68.57 | $705,722 | 383,868 | −2.61% | 10b5-1 |
| Jul 28, 2026 AForm 4 → | Jul 30, 9:02 pm EDT | Hege Elisabeth Sollie-ZetlmayerDirector | 6,000 | — | — | 52,526 | — | |
| Jul 14, 2026 SForm 4 → | Jul 16, 5:20 pm EDT | Pierre GravierCHIEF FINANCIAL OFFICER | 3,494 | $80.35 | $280,743 | 83,986 | −3.99% | 10b5-1 |
| Jul 9, 2026 SForm 4 → | Jul 13, 5:20 pm EDT | Mary L. SmithDirector | 15,834 | $90.00 | $1,425,060 | 21,813 | −42.1% | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 13, 5:20 pm EDT | Mary L. SmithDirector | 15,834 | $42.95 | $680,070 | 27,647 | — | 10b5-1 |
| Jul 9, 2026 SForm 4 → | Jul 13, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 2,464 | $90.25 | $222,376 | 60,299 | −3.93% | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 13, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 2,464 | $46.54 | $114,675 | 62,763 | — | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 8, 5:20 pm EDT | Mark Elliott BouldingEXEC. VP AND CLO | 5,079 | $85.08 | $432,118 | 105,272 | −4.60% | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 8, 5:20 pm EDT | Mark Elliott BouldingEXEC. VP AND CLO | 5,079 | $43.36 | $220,243 | 108,085 | — | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 8, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 46,774 | $87.52 | $4,093,482 | 60,299 | −43.7% | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 8, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 46,774 | $38.86 | $1,817,844 | 84,912 | — | 10b5-1 |
| Jun 26, 2026 SForm 4 → | Jun 30, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 8,130 | $85.26 | $693,151 | 60,137 | −11.9% | 10b5-1 |
| Jun 26, 2026 MForm 4 → | Jun 30, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 8,130 | $38.10 | $309,753 | 67,855 | — | 10b5-1 |
| Jun 24, 2026 SForm 4 → | Jun 26, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 26,283 | $85.78 | $2,254,463 | 60,137 | −30.4% | 10b5-1 |
| Jun 24, 2026 MForm 4 → | Jun 26, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 26,283 | $38.11 | $1,001,514 | 60,237 | — | 10b5-1 |
| Jun 22, 2026 SForm 4 → | Jun 24, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 23,749 | $80.90 | $1,921,378 | 60,137 | −28.3% | 10b5-1 |
| Jun 22, 2026 MForm 4 → | Jun 24, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 23,749 | $25.69 | $610,112 | 83,886 | — | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 22, 5:20 pm EDT | Christine Marie UtterSVP, CHIEF ACCOUNTING OFFICER | 19,686 | $75.56 | $1,487,474 | 70,199 | −21.9% | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 5:20 pm EDT | Christine Marie UtterSVP, CHIEF ACCOUNTING OFFICER | 19,686 | $25.69 | $505,733 | 89,885 | — | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 22, 5:20 pm EDT | Mark Elliott BouldingEXEC. VP AND CLO | 10,462 | $78.65 | $822,868 | 105,272 | −9.04% | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 5:20 pm EDT | Mark Elliott BouldingEXEC. VP AND CLO | 10,522 | $46.54 | $489,694 | 107,284 | — | 10b5-1 |
| Jun 10, 2026 MForm 4 → | Jun 12, 5:30 pm EDT | Eric PauwelsCHIEF BUSINESS OFFICER | 17,566 | $18.01 | $316,364 | 90,977 | — | 10b5-1 |
| Jun 10, 2026 SForm 4 → | Jun 12, 5:30 pm EDT | Eric PauwelsCHIEF BUSINESS OFFICER | 21,277 | $75.00 | $1,595,775 | 73,411 | −22.5% | 10b5-1 |
| Mar 5, 2019 MForm 4 → | Mar 7, 9:31 pm EST | Christine Marie UtterPrincipal Financial Officer | 26,200 | $12.55 | $328,852 | 11,237 | — | plan? |
| Mar 5, 2019 SForm 4 → | Mar 7, 9:31 pm EST | Christine Marie UtterPrincipal Financial Officer | 28,709 | $34.97 | $1,003,824 | 4,937 | −85.3% | plan? |
| Jan 25, 2019 PForm 4 → | Jan 29, 4:15 pm EST | Michael SchmertzlerDirector | 66,225 | $30.20 | $1,999,995 | 1,386,594 | +5.02% | plan? |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:46 pm EST | Stuart Walter PeltzChief Executive Officer, Director | 4,620 | — | — | 22,158 | — | plan? |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:45 pm EST | Neil Gregory AlmsteadChief Technical Ops Officer | 570 | — | — | 6,219 | — | plan? |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:45 pm EST | Marcio SouzaChief Operating Officer | 1,925 | — | — | 4,667 | — | plan? |
| Jan 7, 2019 SForm 4 → | Jan 9, 5:14 pm EST | Neil Gregory AlmsteadChief Technical Ops Officer | 653 | $34.75 | $22,692 | 5,649 | −10.4% | plan? |
| Jan 7, 2019 SForm 4 → | Jan 9, 5:12 pm EST | Marcio SouzaChief Operating Officer | 83 | $34.75 | $2,884 | 2,742 | −2.94% | plan? |
| Jan 7, 2019 SForm 4 → | Jan 9, 5:11 pm EST | Christine Marie UtterPrincipal Financial Officer | 297 | $34.75 | $10,321 | 7,446 | −3.84% | plan? |
| Jan 7, 2019 SForm 4 → | Jan 9, 5:09 pm EST | Stuart Walter PeltzChief Executive Officer, Director | 2,512 | $34.75 | $87,292 | 17,538 | −12.5% | plan? |
| Jun 19, 2018 SForm 4 → | Jun 21, 4:33 pm EDT | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 20,000 | $48.31 | $966,240 | 17,154 | −53.8% | plan? |
| Jun 19, 2018 MForm 4 → | Jun 21, 4:33 pm EDT | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 20,000 | $10.85 | $217,000 | 37,154 | — | plan? |
| Jun 1, 2018 SForm 4 → | Jun 4, 4:22 pm EDT | Marcio SouzaChief Operating Officer | 5,161 | $34.65 | $178,829 | 63,071 | −7.56% | plan? |
| Jan 5, 2018 SForm 4 → | Jan 9, 5:59 pm EST | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 703 | $18.03 | $12,675 | 5,125 | −12.1% | plan? |
| Jan 5, 2018 SForm 4 → | Jan 9, 5:59 pm EST | Stuart Walter PeltzChief Executive Officer, Director | 2,230 | $18.03 | $40,207 | 26,646 | −7.72% | plan? |
| Jan 4, 2018 SForm 4 → | Jan 5, 4:09 pm EST | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 77 | $17.67 | $1,361 | 5,207 | −1.46% | plan? |
| Jan 4, 2018 SForm 4 → | Jan 5, 4:07 pm EST | Christine Marie UtterPrincipal Financial Officer | 412 | $17.67 | $7,280 | 6,660 | −5.83% | plan? |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:09 pm EST | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 874 | — | — | 5,284 | — | plan? |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:08 pm EST | Marcio SouzaChief Operating Officer | 1,079 | — | — | 1,742 | — | plan? |
| May 31, 2017 AForm 4 → | Jun 2, 6:54 pm EDT | Marcio SouzaChief Operating Officer | 30,000 | — | — | 36,457 | — | plan? |
| May 24, 2017 MForm 4 → | May 25, 4:18 pm EDT | Mark RotheraChief Commercial Officer | 2,000 | $10.85 | $21,700 | 33,739 | — | plan? |
| May 23, 2017 PForm 4 → | May 24, 4:17 pm EDT | Dawn SvoronosDirector | 25,000 | $13.49 | $337,230 | 25,000 | — | plan? |
| May 9, 2017 MForm 4 → | May 11, 5:20 pm EDT | Shane William Charles KovacsChief Financial Officer | 10,000 | $10.85 | $108,500 | 37,850 | — | plan? |
| Apr 28, 2017 JForm 4 → | May 2, 8:09 pm EDT | Complete Pharma Holdings II, LLC10% Owner | 6,683,598 | — | — | 0 | — | plan? |
| Mar 15, 2017 MForm 4 → | Mar 17, 4:42 pm EDT | Mark RotheraChief Commercial Officer | 2,966 | $10.85 | $32,181 | 31,739 | — | plan? |
| Feb 16, 2017 MForm 4 → | Feb 17, 6:14 pm EST | Mark RotheraChief Commercial Officer | 3,125 | $10.85 | $33,906 | 28,773 | — | plan? |
| Jan 17, 2017 MForm 4 → | Jan 17, 4:35 pm EST | Mark RotheraChief Commercial Officer | 3,125 | $10.85 | $33,906 | 25,648 | — | plan? |
| Jan 5, 2017 SForm 4 → | Jan 6, 6:01 pm EST | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 78 | $11.82 | $922 | 2,687 | −2.82% | plan? |
| Jan 3, 2017 AForm 4 → | Jan 5, 9:49 pm EST | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 6,720 | — | — | 2,765 | — | plan? |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:13 pm EST | Tuyen OngChief Medical Officer | 6,000 | — | — | 6,000 | — | plan? |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:13 pm EST | Stuart Walter PeltzChief Executive Officer, Director | 21,600 | — | — | 28,876 | — | plan? |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:12 pm EST | Mark RotheraChief Commercial Officer | 9,600 | — | — | 22,523 | — | plan? |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:12 pm EST | Shane William Charles KovacsChief Financial Officer | 9,000 | — | — | 27,850 | — | plan? |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:12 pm EST | Mark Elliott BouldingExec. VP and CLO | 9,000 | — | — | 27,034 | — | plan? |
| Nov 14, 2016 MForm 4 → | Nov 14, 5:38 pm EST | Mark RotheraChief Commercial Officer | 1,941 | $10.85 | $21,060 | 11,216 | — | plan? |
| Oct 10, 2016 MForm 4 → | Oct 11, 6:12 am EDT | Mark RotheraChief Commercial Officer | 1,950 | $10.85 | $21,158 | 9,275 | — | plan? |
| Sep 27, 2016 MForm 4 → | Sep 27, 4:24 pm EDT | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 10,000 | $10.85 | $108,500 | 10,000 | — | plan? |
| Sep 26, 2016 MForm 4 → | Sep 26, 4:37 pm EDT | Shane William Charles KovacsChief Financial Officer | 10,000 | $10.85 | $108,500 | 18,850 | — | plan? |
| Sep 26, 2016 MForm 4 → | Sep 26, 4:36 pm EDT | Mark RotheraChief Commercial Officer | 2,200 | $10.85 | $23,870 | 7,325 | — | plan? |
| Sep 23, 2016 MForm 4 → | Sep 26, 4:39 pm EDT | Michael SchmertzlerDirector | 60,000 | $10.85 | $651,000 | 86,766 | — | plan? |
| Mar 3, 2016 PForm 4 → | Mar 7, 7:12 am EST | Mark RotheraChief Commercial Officer | 2,000 | $6.23 | $12,460 | 5,125 | +64.0% | plan? |
| Jan 15, 2016 MForm 4 → | Jan 15, 8:11 pm EST | Mark RotheraChief Commercial Officer | 3,125 | $10.85 | $33,906 | 3,125 | — | plan? |
| Oct 20, 2015 GForm 5 → | Jan 15, 2016, 8:06 pm EST | Mark RotheraChief Commercial Officer | 18,432 | — | — | 9,216 | — | plan? |
| Jul 21, 2015 MForm 4 → | Jul 21, 5:19 pm EDT | Mark RotheraChief Commercial Officer | 9,216 | $10.85 | $99,994 | 9,216 | — | plan? |
| Jul 6, 2015 SForm 4 → | Jul 6, 9:21 pm EDT | David P SouthwellDirector | 23,604 | $47.52 | $1,121,694 | 0 | −100% | plan? |
| Jul 6, 2015 MForm 4 → | Jul 6, 9:21 pm EDT | David P SouthwellDirector | 15,000 | $10.85 | $162,750 | 23,604 | — | plan? |
| Jun 18, 2015 SForm 4 → | Jun 19, 5:18 pm EDT | Allan Steven JacobsonDirector | 5,000 | $50.13 | $250,650 | 6,848 | −42.2% | plan? |
| Jun 17, 2015 MForm 4 → | Jun 17, 4:47 pm EDT | Stuart Walter PeltzChief Executive Officer, Director | 3,500 | $10.85 | $37,975 | 7,276 | — | plan? |
| Jun 8, 2015 SForm 4 → | Jun 10, 6:01 pm EDT | Mark Elliott BouldingExec VP and CLO | 56,849 | $55.04 | $3,128,737 | 16,327 | −77.7% | plan? |
| Jun 8, 2015 MForm 4 → | Jun 10, 6:01 pm EDT | Mark Elliott BouldingExec VP and CLO | 62,083 | $10.85 | $673,601 | 73,176 | — | plan? |
| Jun 8, 2015 SForm 4 → | Jun 10, 6:01 pm EDT | Stuart Walter PeltzChief Executive Officer, Director | 100,000 | $54.49 | $5,448,791 | 3,776 | −96.4% | plan? |
| Jun 8, 2015 MForm 4 → | Jun 10, 6:01 pm EDT | Stuart Walter PeltzChief Executive Officer, Director | 103,776 | $10.85 | $1,125,970 | 30,076 | — | plan? |
| Jun 8, 2015 SForm 4 → | Jun 10, 6:00 pm EDT | Richard AldrichDirector | 7,000 | $55.66 | $389,592 | 0 | −100% | plan? |
| Jun 8, 2015 MForm 4 → | Jun 10, 6:00 pm EDT | Richard AldrichDirector | 7,000 | $10.85 | $75,950 | 7,000 | — | plan? |
| May 22, 2015 SForm 4 → | May 22, 6:07 pm EDT | Shane William Charles KovacsChief Financial Officer | 82,491 | $55.41 | $4,570,814 | 8,850 | −90.3% | plan? |
| May 22, 2015 MForm 4 → | May 22, 6:07 pm EDT | Shane William Charles KovacsChief Financial Officer | 78,991 | $14.67 | $1,158,632 | 91,341 | — | plan? |
| May 15, 2015 JForm 4 → | May 19, 8:14 pm EDT | Michael SchmertzlerDirector | 3,721 | — | — | 0 | — | plan? |
| May 7, 2015 JForm 4 → | May 11, 7:35 pm EDT | Michael SchmertzlerDirector | 1,126,570 | — | — | 3,721 | — | plan? |
| Apr 15, 2015 SForm 4 → | Apr 17, 6:56 pm EDT | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 9,511 | $68.65 | $652,913 | 0 | −100% | plan? |
| Mar 23, 2015 SForm 4 → | Mar 23, 6:01 pm EDT | Stuart Walter PeltzChief Executive Officer, Director | 47,200 | $69.14 | $3,263,428 | 0 | −100% | plan? |
| Mar 23, 2015 SForm 4 → | Mar 23, 5:58 pm EDT | David P SouthwellDirector | 2,317 | $69.04 | $159,957 | 8,604 | −21.2% | plan? |
| Mar 20, 2015 SForm 4 → | Mar 23, 6:03 pm EDT | Mark Elliott BouldingExec. VP and CLO | 21,142 | $68.12 | $1,440,247 | 11,093 | −65.6% | plan? |
| Mar 19, 2015 SForm 4 → | Mar 23, 6:04 pm EDT | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 20,370 | $70.02 | $1,426,240 | 9,511 | −68.2% | plan? |
| Mar 18, 2015 SForm 4 → | Mar 18, 7:27 pm EDT | Allan Steven JacobsonDirector | 16,616 | $76.00 | $1,262,790 | 11,848 | −58.4% | plan? |
| Mar 17, 2015 SForm 4 → | Mar 18, 7:26 pm EDT | Mark RotheraChief Commercial Officer | 10,700 | $76.64 | $820,048 | 0 | −100% | plan? |
| Mar 17, 2015 MForm 4 → | Mar 18, 7:26 pm EDT | Mark RotheraChief Commercial Officer | 10,700 | $10.85 | $116,095 | 10,700 | — | plan? |
| Mar 16, 2015 SForm 4 → | Mar 18, 7:26 pm EDT | Michael L KrandaDirector | 2,500 | $72.81 | $182,037 | 2,242 | −52.7% | plan? |
| Mar 13, 2015 SForm 4 → | Mar 13, 6:03 pm EDT | Robert J. SpiegelChief Medical Officer | 1,030 | $75.10 | $77,355 | 3,239 | −24.1% | plan? |
| Mar 13, 2015 SForm 4 → | Mar 13, 6:02 pm EDT | Mark RotheraChief Commercial Officer | 300 | $76.36 | $22,908 | 0 | −100% | plan? |
| Mar 13, 2015 MForm 4 → | Mar 13, 6:02 pm EDT | Mark RotheraChief Commercial Officer | 300 | $10.85 | $3,255 | 300 | — | plan? |
| Mar 10, 2015 SForm 4 → | Mar 11, 8:09 pm EDT | Neil Gregory AlmsteadEVP, Research and CMC | 79 | $70.71 | $5,586 | 1,295 | −5.75% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 MForm 4 → | Aug 19, 5:20 pm EDT | Mark Elliott BouldingEXEC. VP AND CLO | 2,813 | — | — | 16,876 | — | 10b5-1 |
| Jul 28, 2026 AForm 4 → | Jul 30, 9:02 pm EDT | Hege Elisabeth Sollie-ZetlmayerDirector | 5,213 | — | — | 1,738 | — | |
| Jul 9, 2026 MForm 4 → | Jul 13, 5:20 pm EDT | Mary L. SmithDirector | 15,834 | — | — | 0 | — | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 13, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 2,464 | — | — | 45,036 | — | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 8, 5:20 pm EDT | Mark Elliott BouldingEXEC. VP AND CLO | 5,039 | — | — | 28,125 | — | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 8, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 46,774 | — | — | 9,063 | — | 10b5-1 |
| Jun 26, 2026 MForm 4 → | Jun 30, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 8,130 | — | — | 19,687 | — | 10b5-1 |
| Jun 24, 2026 MForm 4 → | Jun 26, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 26,283 | — | — | 36,150 | — | 10b5-1 |
| Jun 22, 2026 MForm 4 → | Jun 24, 5:20 pm EDT | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | 23,749 | — | — | 23,751 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 5:20 pm EDT | Christine Marie UtterSVP, CHIEF ACCOUNTING OFFICER | 19,686 | — | — | 15,314 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 5:20 pm EDT | Mark Elliott BouldingEXEC. VP AND CLO | 10,522 | — | — | 30,938 | — | 10b5-1 |
| Jun 10, 2026 SForm 4 → | Jun 12, 5:30 pm EDT | Eric PauwelsCHIEF BUSINESS OFFICER | 17,566 | — | — | 0 | — | 10b5-1 |
| Mar 5, 2019 MForm 4 → | Mar 7, 9:31 pm EST | Christine Marie UtterPrincipal Financial Officer | 26,200 | $12.63 | $316,374 | 6,300 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:53 pm EST | Christine Marie UtterPrincipal Financial Officer | 52,600 | — | — | 10,100 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:53 pm EST | Mark Elliott BouldingExec. VP and CLO | 90,000 | — | — | 17,500 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:53 pm EST | Michael SchmertzlerDirector | 28,000 | — | — | 28,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:52 pm EST | Glenn Steele Jr. M.D. Ph.D.Director | 14,000 | — | — | 14,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:50 pm EST | Dawn SvoronosDirector | 14,000 | — | — | 14,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:50 pm EST | Stephanie OkeyDirector | 14,000 | — | — | 14,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:50 pm EST | Jerome B ZeldisDirector | 14,000 | — | — | 14,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:48 pm EST | Emma ReeveDirector | 14,000 | — | — | 14,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:47 pm EST | David P SouthwellDirector | 14,000 | — | — | 14,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:47 pm EST | Allan Steven JacobsonDirector | 14,000 | — | — | 14,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:46 pm EST | Stuart Walter PeltzChief Executive Officer, Director | 346,950 | — | — | 26,950 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:45 pm EST | Neil Gregory AlmsteadChief Technical Ops Officer | 90,000 | — | — | 17,500 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 5:45 pm EST | Marcio SouzaChief Operating Officer | 144,325 | — | — | 6,825 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 8:46 am EST | Stephanie OkeyDirector | 15,167 | — | — | 1,167 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 8:43 am EST | Emma ReeveDirector | 15,167 | — | — | 1,167 | — | |
| Jun 19, 2018 MForm 4 → | Jun 21, 4:33 pm EDT | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 20,000 | $10.85 | $217,000 | 46,898 | — | |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:17 pm EST | Glenn Steele Jr. M.D. Ph.D.Director | 14,000 | — | — | 14,000 | — | |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:16 pm EST | Allan Steven JacobsonDirector | 14,000 | — | — | 14,000 | — | |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:16 pm EST | Jerome B ZeldisDirector | 14,000 | — | — | 14,000 | — | |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:15 pm EST | David P SouthwellDirector | 14,000 | — | — | 14,000 | — | |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:14 pm EST | Dawn SvoronosDirector | 14,000 | — | — | 14,000 | — | |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:11 pm EST | Michael SchmertzlerDirector | 28,000 | — | — | 28,000 | — | |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:09 pm EST | Mark Elliott BouldingExec. VP and CLO | 70,000 | — | — | 70,000 | — | |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:09 pm EST | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 70,000 | — | — | 70,000 | — | |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:08 pm EST | Marcio SouzaChief Operating Officer | 77,696 | — | — | 2,696 | — | |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:07 pm EST | Christine Marie UtterPrincipal Financial Officer | 40,000 | — | — | 40,000 | — | |
| Jan 3, 2018 AForm 4 → | Jan 5, 4:05 pm EST | Stuart Walter PeltzChief Executive Officer, Director | 200,000 | — | — | 200,000 | — | |
| Jun 2, 2017 AForm 4 → | Jun 6, 6:25 pm EDT | Christine Marie UtterPrincipal Financial Officer | 25,000 | — | — | 25,000 | — | |
| May 31, 2017 AForm 4 → | Jun 2, 6:54 pm EDT | Marcio SouzaChief Operating Officer | 30,000 | $12.53 | $375,900 | 30,000 | — | |
| May 24, 2017 MForm 4 → | May 25, 4:18 pm EDT | Mark RotheraChief Commercial Officer | 2,000 | — | — | 6,125 | — | |
| May 9, 2017 MForm 4 → | May 11, 5:20 pm EDT | Shane William Charles KovacsChief Financial Officer | 10,000 | — | — | 45,625 | — | |
| Mar 15, 2017 MForm 4 → | Mar 17, 4:42 pm EDT | Mark RotheraChief Commercial Officer | 2,966 | — | — | 69,227 | — | |
| Feb 16, 2017 MForm 4 → | Feb 17, 6:14 pm EST | Mark RotheraChief Commercial Officer | 3,125 | — | — | 72,193 | — | |
| Jan 17, 2017 MForm 4 → | Jan 17, 4:35 pm EST | Mark RotheraChief Commercial Officer | 3,125 | — | — | 75,318 | — | |
| Jan 3, 2017 AForm 4 → | Jan 9, 5:39 pm EST | David P SouthwellDirector | 12,000 | — | — | 12,000 | — | late |
| Jan 3, 2017 AForm 4 → | Jan 5, 9:49 pm EST | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 35,000 | — | — | 35,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:25 pm EST | Jerome B ZeldisDirector | 12,000 | — | — | 12,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:25 pm EST | Michael SchmertzlerDirector | 24,000 | — | — | 24,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:24 pm EST | Ronald C Renaud Jr.Director | 12,000 | — | — | 12,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:24 pm EST | Allan Steven JacobsonDirector | 12,000 | — | — | 12,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:24 pm EST | Adam KoppelDirector | 12,000 | — | — | 12,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:23 pm EST | Dawn SvoronosDirector | 12,000 | — | — | 12,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:23 pm EST | Glenn Steele Jr. M.D. Ph.D.Director | 12,000 | — | — | 12,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:23 pm EST | Cameron Geoffrey McDonoughDirector | 12,000 | — | — | 12,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:13 pm EST | Tuyen OngChief Medical Officer | 35,000 | — | — | 35,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:13 pm EST | Stuart Walter PeltzChief Executive Officer, Director | 126,000 | — | — | 126,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:12 pm EST | Mark RotheraChief Commercial Officer | 56,000 | — | — | 56,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:12 pm EST | Shane William Charles KovacsChief Financial Officer | 52,500 | — | — | 52,500 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:12 pm EST | Mark Elliott BouldingExec. VP and CLO | 52,500 | — | — | 52,500 | — | |
| Nov 14, 2016 MForm 4 → | Nov 14, 5:38 pm EST | Mark RotheraChief Commercial Officer | 1,941 | — | — | 78,443 | — | |
| Oct 10, 2016 MForm 4 → | Oct 11, 6:12 am EDT | Mark RotheraChief Commercial Officer | 1,950 | — | — | 80,384 | — | |
| Sep 27, 2016 MForm 4 → | Sep 27, 4:24 pm EDT | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 10,000 | $10.85 | $108,500 | 3,102 | — | |
| Sep 26, 2016 MForm 4 → | Sep 26, 4:37 pm EDT | Shane William Charles KovacsChief Financial Officer | 10,000 | — | — | 55,625 | — | |
| Sep 26, 2016 MForm 4 → | Sep 26, 4:36 pm EDT | Mark RotheraChief Commercial Officer | 2,200 | — | — | 82,334 | — | |
| Sep 23, 2016 MForm 4 → | Sep 26, 4:39 pm EDT | Michael SchmertzlerDirector | 60,000 | — | — | 0 | — | |
| Jun 10, 2016 AForm 4 → | Jun 13, 4:48 pm EDT | Dawn SvoronosDirector | 20,000 | — | — | 20,000 | — | |
| Jan 15, 2016 MForm 4 → | Jan 15, 8:11 pm EST | Mark RotheraChief Commercial Officer | 3,125 | — | — | 84,534 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:42 pm EST | Mark RotheraChief Commercial Officer | 70,000 | — | — | 70,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:41 pm EST | Neil Gregory AlmsteadEVP Research Pharma Ops & Tech | 55,000 | — | — | 55,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:40 pm EST | Mark Elliott BouldingExec. VP and CLO | 70,000 | — | — | 70,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:39 pm EST | Shane William Charles KovacsEVP, CFO & Head of Corp Dev | 80,000 | — | — | 80,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:38 pm EST | Stuart Walter PeltzChief Executive Officer, Director | 175,000 | — | — | 175,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:36 pm EST | Robert J. SpiegelChief Medical Officer | 10,000 | — | — | 10,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:32 pm EST | Allan Steven JacobsonDirector | 12,000 | — | — | 12,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:31 pm EST | Michael SchmertzlerDirector | 24,000 | — | — | 24,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:30 pm EST | Adam KoppelDirector | 12,000 | — | — | 12,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:28 pm EST | Cameron Geoffrey McDonoughDirector | 12,000 | — | — | 12,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:27 pm EST | Ronald C Renaud Jr.Director | 12,000 | — | — | 12,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:27 pm EST | David P SouthwellDirector | 12,000 | — | — | 12,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:25 pm EST | Jerome B ZeldisDirector | 12,000 | — | — | 12,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:25 pm EST | Glenn Steele Jr. M.D. Ph.D.Director | 12,000 | — | — | 12,000 | — | |
| Jul 21, 2015 MForm 4 → | Jul 21, 5:19 pm EDT | Mark RotheraChief Commercial Officer | 9,216 | — | — | 87,659 | — | |
| Jul 6, 2015 MForm 4 → | Jul 6, 9:21 pm EDT | David P SouthwellDirector | 15,000 | — | — | 15,000 | — | |
| Jun 17, 2015 MForm 4 → | Jun 17, 4:47 pm EDT | Stuart Walter PeltzChief Executive Officer, Director | 3,500 | — | — | 353,030 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 6:35 am EDT | Glenn Steele Jr. M.D. Ph.D.Director | 20,000 | — | — | 20,000 | — | |
| Jun 8, 2015 MForm 4 → | Jun 10, 6:01 pm EDT | Mark Elliott BouldingExec VP and CLO | 62,083 | — | — | 50,000 | — | |
| Jun 8, 2015 MForm 4 → | Jun 10, 6:01 pm EDT | Stuart Walter PeltzChief Executive Officer, Director | 103,776 | — | — | 356,530 | — | |
| Jun 8, 2015 MForm 4 → | Jun 10, 6:00 pm EDT | Richard AldrichDirector | 7,000 | — | — | 13,000 | — | |
| May 22, 2015 MForm 4 → | May 22, 6:07 pm EDT | Shane William Charles KovacsChief Financial Officer | 78,991 | — | — | 46,384 | — | |
| Mar 17, 2015 MForm 4 → | Mar 18, 7:26 pm EDT | Mark RotheraChief Commercial Officer | 10,700 | — | — | 8,125 | — | |
| Mar 13, 2015 MForm 4 → | Mar 13, 6:02 pm EDT | Mark RotheraChief Commercial Officer | 300 | — | — | 106,325 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 7:40 pm EST | Mark RotheraChief Commercial Officer | 32,000 | — | — | 9,375 | — | |
| Feb 17, 2015 MForm 4 → | Feb 20, 5:51 pm EST | Neil Gregory AlmsteadEVP, Research and CMC | 3,904 | — | — | 9,688 | — | late |
| Jan 20, 2015 MForm 4 → | Jan 22, 9:05 pm EST | Neil Gregory AlmsteadEVP, Research and CMC | 26,096 | — | — | 73,904 | — | |
| Jan 16, 2015 MForm 4 → | Jan 16, 7:37 pm EST | Mark RotheraChief Commercial Officer | 2,300 | — | — | 138,000 | — | |
| Jan 15, 2015 MForm 4 → | Jan 16, 7:35 pm EST | Claudia de Oliveira Ribeiro HirawatPresident | 2,396 | — | — | 67,084 | — | |
| Jan 13, 2015 MForm 4 → | Jan 15, 7:43 pm EST | Mark RotheraChief Commercial Officer | 6,700 | — | — | 140,300 | — |